(Q41627645)

5 October 2017

Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315687

12 September 2022

0 references

5

Lambris JD

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315687

12 September 2022

author name string

Hedrick JA

1

1 reference

5 October 2017

Watry D

2

1 reference

5 October 2017

Speiser C

3

1 reference

5 October 2017

O'Donnell P

4

1 reference

5 October 2017

Tsoukas CD

6

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 May 1992

1 reference

European Journal of Immunology

5 October 2017

1 reference

5 October 2017

22

1 reference

5 October 2017

5

1 reference

5 October 2017

1123-1131

1 reference

Low circulating thymulin-like activity in children with AIDS and AIDS-related complex.

5 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

Recent progress in Epstein-Barr virus research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Detection of Antigens Associated With Epstein-Barr Virus Replication in Extracts From Biopsy Specimens of Nasopharyngeal Carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA+ T-cell lymphoma containing linear, EBV DNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Membrane complement receptors specific for bound fragments of C3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Epstein-Barr virus receptors on human pharyngeal epithelia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Human epithelial cell expression of an Epstein-Barr virus receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Infection of human thymocytes by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Infection of the human T-cell-derived leukemia line Molt-4 by Epstein-Barr virus (EBV): Induction of EBV-determined antigens and virus reproduction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Northern and Southern blots

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Selective extraction of polyoma DNA from infected mouse cell cultures

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Early events in the infection of human B lymphocytes by Epstein-Barr virus: The internalization process

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Decay-accelerating factor: biochemistry, molecular biology, and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Structure-function relationships of the complement components

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Viral receptors of the immunoglobulin superfamily

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220504

7 January 2021

Identifiers

DOI

10.1002/EJI.1830220504

1 reference

5 October 2017

1 reference